(Q40488130)

21 September 2017

title

A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein (English)

1 reference

21 September 2017

1 reference

1 reference

Chun Zhou

1

1 reference

21 September 2017

Sharareh Emadi

series ordinal

2

1 reference

21 September 2017

Michael R Sierks

series ordinal

3

1 reference

21 September 2017

Anne Messer

series ordinal

4

1 reference

21 September 2017

publication date

1 December 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

10

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

1023-1031

1 reference

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Alpha-synuclein in Lewy body disease and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Alpha-synuclein in Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Caught in the act: alpha-synuclein is the culprit in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

alpha-Synuclein locus triplication causes Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Yeast cells provide insight into alpha-synuclein biology and pathobiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

A Drosophila model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

The role of alpha-synuclein in Parkinson's disease: insights from animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Accumulation of Insoluble α-Synuclein in Dementia with Lewy Bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Intrabody and intrakine strategies for molecular therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

A single-chain Fv intrabody provides functional protection against the effects of mutant protein in an organotypic slice culture model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Isolation of high affinity human antibodies directly from large synthetic repertoires.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Induction of alpha-synuclein aggregation by intracellular nitrative insult.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Antineoplastic effect of anti-erbB-2 intrabody is not correlated with scFv affinity for its target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

cDNA sequence analysis of monoclonal antibodies against the human placental acidic isoferritin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

The possible role of adhesion in synaptic modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Development of new treatments for Parkinson's disease in transgenic animal models: a role for beta-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Efficient generation of stably electrotransfected human hematopoietic cell lines without drug selection by consecutive FACsorting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

Antigen-stimulated dissociation of BCR mIg from Ig-alpha/Ig-beta: implications for receptor desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.08.019

10.1016/J.YMTHE.2004.08.019

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference